| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 6 | +62.2 M | 100% | $0.94 | +$58.3 M |
| Sells | 0 | ||||
| Net | +6 | +62.2 M | 100% | +$58.3 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Lantheus Alpha Therapy, LLC | 10%+ Owner | $111 M | +$57.4 M | +107% | Mar 6, 2024 |
| Markus Puhlmann | Chief Medical Officer | $687 K | +$329 K | +91.7% | Jun 20, 2024 |
| Robert F. Williamson III | Director | $590 K | +$319 K | +118% | Jun 20, 2024 |
| Johan M. Spoor | CEO, Director | $244 K | +$117 K | +93% | Jun 20, 2024 |
| Lori A. Woods | Director | $194 K | +$100 K | +107% | Jun 20, 2024 |
| Jonathan Hunt | Chief Financial Officer | $42.2 K | +$67.3 K | Jun 20, 2024 | |
| Mark Austin | VP Finance/Prin Fin&Acct Offic | $30.3 K | Apr 23, 2024 | ||
| Jennifer Streeter | COO & VP of HR | $25.6 K | Jun 12, 2023 | ||
| Alan Hoffmann | Director | Jul 21, 2022 | |||
| William Cavanagh | Chief R&D Officer | Jul 21, 2022 | |||
| Philip J. Vitale | Director | Jul 21, 2022 | |||
| Frank Morich | Director | Jun 20, 2024 | |||
| Michael McCormick | Director | Feb 21, 2023 | |||
| Heidi Henson | Director | Jun 20, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|